Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes

Mol Ther. 2021 Nov 3;29(11):3219-3229. doi: 10.1016/j.ymthe.2021.06.021. Epub 2021 Jul 2.

Abstract

Alpha-1 antitrypsin deficiency (AATD) is most commonly caused by the Z mutation, a single-base substitution that leads to AAT protein misfolding and associated liver and lung disease. In this study, we apply adenine base editors to correct the Z mutation in patient induced pluripotent stem cells (iPSCs) and iPSC-derived hepatocytes (iHeps). We demonstrate that correction of the Z mutation in patient iPSCs reduces aberrant AAT accumulation and increases its secretion. Adenine base editing (ABE) of differentiated iHeps decreases ER stress in edited cells, as demonstrated by single-cell RNA sequencing. We find ABE to be highly efficient in iPSCs and do not identify off-target genomic mutations by whole-genome sequencing. These results reveal the feasibility and utility of base editing to correct the Z mutation in AATD patient cells.

Keywords: adenine base editor; alpha-1 antitrypsin deficiency; base edit; hepatocyte; human induced pluripotent stem cells; iHep; iPSC; single cell RNA sequencing; whole genome sequencing.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine*
  • Biomarkers
  • CRISPR-Cas Systems*
  • Cell Differentiation / genetics
  • Cells, Cultured
  • Endoplasmic Reticulum Stress
  • Gene Editing*
  • Gene Expression
  • Hepatocytes / cytology
  • Hepatocytes / metabolism*
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / metabolism*
  • Mutation
  • alpha 1-Antitrypsin / chemistry
  • alpha 1-Antitrypsin / genetics*
  • alpha 1-Antitrypsin Deficiency / genetics*
  • alpha 1-Antitrypsin Deficiency / therapy*

Substances

  • Biomarkers
  • alpha 1-Antitrypsin
  • Adenine